-
Shell completes sale of Jiffy Lube International and Premium Velocity Auto to Monomoy Capital Partners
HOUSTON, July 1, 2026 /PRNewswire/ — Pennzoil Quaker State Company DBA SOPUS Products, a wholly owned subsidiary of Shell USA, Inc., that comprises Shell’s United States (“U.S.”) lubricants business, has completed the previously announced sale of Jiffy Lube International (JLI) and its subsidiary Premium Velocity Auto (PVA) LLC business to an affiliate of Monomoy Capital…
-
GNI Group Completes Acquisition of AYUMI Pharmaceutical
TOKYO, July 01, 2026 (GLOBE NEWSWIRE) — GNI Group Ltd. (TSE: 2160, “GNI Group” or the “Company”) today announced that it has completed the acquisition of all shares of Ayumi Pharmaceutical Holdings Co., Ltd. from shareholders led by Blackstone. As a result, Ayumi Pharmaceutical Holdings Co., Ltd. and its subsidiary, Ayumi Pharmaceutical Co., Ltd. (“Ayumi…
-
US C5ISR Funding Reaches $42.7 Billion as AI, Open Architectures, and Next-Generation Technologies Reshape Defense Modernization
Frost & Sullivan identifies significant growth opportunities across quantum technologies, edge integration, and the Internet of Battlefield Things SILICON VALLEY, Calif., June 18, 2026 /PRNewswire/ — Frost & Sullivan’s latest analysis, C5ISR Industry, United States, 2025–2030, finds that growing geopolitical tensions, rapid advances in artificial intelligence (AI), and increasing adoption of open-architecture defense systems are…
-
Nicole Junkermann Highlights India as Key Market for Sports Format Innovation
T20 cricket didn’t emerge from a boardroom in London or a sports science lab in the United States. It emerged because India demanded it. Shorter. Faster. More suited to the attention patterns of a young, mobile, time-compressed audience. It then became one of the most valuable sporting formats ever created, exported globally and imitated across…
-
Morepen Labs' Facility Clears USFDA Inspection with NIL Adverse Observation for the Record Fourth Consecutive Time
Company sets a benchmark again in pharmaceutical excellence reinforcing its global leadership in quality and regulatory compliance Gurugram, Haryana, India Morepen Laboratories Limited (NSE: MOREPENLAB; BSE: 500288) has announced the successful completion of a USFDA (United States Food and Drug Administration) inspection at its Masulakhanna (Himachal) facility, with Zero adverse observations (No Form 483 issued…
Latest News
About the Author
We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.
